Cholesterol, arterial inflammation and destabilization of atherosclerotic plaque: new indications and new weapons

Prof. Alberto Cossini (Milan, Italy) provides an overview of the current guidelines about the LDL levels, explains the mechanism of action of the PCSK9 inhibitors and discusses novel therapies for lipids disorders.